Eva Caroff
14Patents
5h-index
16Co-inventors
59Inventor score
Filing activity: Mar 22, 2004 → Jan 14, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8048881B2 | Pyrimidine derivatives and their use as P2Y12 receptor antagonists | Chemistry; Metallurgy | 9 | Active |
| US8518912B2 | Phosphonic acid derivates and their use as P2Y12 receptor antagonists | Chemistry; Metallurgy | 9 | Active |
| US8288385B2 | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines | Human Necessities | 7 | Active |
| US8058263B2 | Substituted 2-phenyl-pyridine derivatives | Human Necessities | 7 | Active |
| US8466156B2 | 2-phenyl-4-cyclopropyl-pyrimidine derivatives | Human Necessities | 5 | Active |
| US8093250B2 | 2-aminocarbonyl-pyridine derivatives | Chemistry; Metallurgy | 5 | Active |
| US8044055B2 | 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as P2Y12 receptor | Chemistry; Metallurgy | 5 | Active |
| US9266876B2 | 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives | Chemistry; Metallurgy | 4 | Active |
| US8664203B2 | Thiazole derivatives and their use as P2Y12 receptor antagonists | Chemistry; Metallurgy | 4 | Active |
| US10047080B2 | (R)-2-methyl-piperazine derivatives as CXCR3 receptor modulators | Emerging Cross-Sectional Technologies | 1 | Active |
| US10259807B2 | 1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives | Human Necessities | 0 | Active |
| US10053457B2 | Hydroxyalkyl-piperazine derivatives as CXCR3 receptor modulators | Human Necessities | 0 | Active |
| US7727979B2 | Guanidine derivatives and their use as neuropeptide FF receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US9951063B2 | 8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.